The view point in the Republic of South Africa (regulatory
authority being the Medicines Control Council) with regards to the
country of origin, is that it could only be country A. The product
is manufactured in country A which requires adherence to all the
necessary GMP principles, compentency of the people and developmental
data. The registration status of the product in country B is only
a regulatory aspect and does not give the product any other status
than being legally allowed to be sold in country B.
Regards Joey Gouws
"Mev. J Gouws" <HALL188@hltrsa.pwv.gov.za>
Organization: Dept. of Health RSA
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.